Related Topics for
Colorectal Cancer
FEATURES
ONCOLINK ART GALLERY
Cancer Types
Types of Cancer > Gastrointestinal Cancers > Colorectal Cancer > Conferences
Conferences
OncoLink at ASCO 2009
A phase III trial comparing mFOLFOX6 to mFOLFOX6 plus bevacizumab in stage II or III carcinoma of the colon: Results of NSABP Protocol C-08
OncoLink at PTCOG 2006
The protection of the small intestine and colon from carbon ion particle irradiation by means of Gore-Tex soft tissue patches for patients with pelvic tumors
OncoLink at ASCO 2008
Effect of intravenous calcium and magnesium (IV CaMg) on oxaliplatin-induced sensory neurotoxicity (sNT) in adjuvant colon cancer: Results of the phase III placebo-controlled, double blind NCCTG trial N04C7
OncoLink at ASCO 2007
Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases
OncoLink at the 2006 AACR Plenary Session
A phase III, multicenter, randomized controlled trial of panitumumab plus best supportive care (BSC) versus BSC alone in patients with metastatic colorectal cancer
OncoLink at the Chemotherapy Foundation Symposium 2005
Panitumumab, A Fully-Human IgG2 Antibody Treatment for Colorectal Cancer
OncoLink at ASCO 2005
High-dose bevacizumab improved survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: Results from the Eastern Cooperative Oncology Group (ECOG) study E3200
OncoLink at ASCO 2004
HMG CoA reductase inhibitors and the risk of colorectal cancer
OncoLink at the Chemotherapy Foundation Symposium 2003
Alimta and Oxaliplatin in Colorectal Cancer
OncoLink at ASCO 2003
Bevacizumab (a monoclonal antibody to vascular endothelial growth factor) prolongs survival in first-line colorectal cancer (CRC): Results of a phase III trial of bevacizumab in combination with bolus IFL (irinotecan, 5-fluoruracil, leucovorin) as first-line therapy in subjects with metastatic CRC
OncoLink at ASCO 2002
Cetuximab (C225) Plus Irinotecan (CPT-11) Plus Infusional 5FU/Folinic Acid (FA) is Safe and Active in Metastatic Colorectal Cancer (MCRC) that Expresses Epidermal Growth Factor Receptor (EGFR)
OncoLink at ASCO 2001
American Cancer Society Award Winner Sidney Winawer, MD, Discusses the Progress and Promise of Colorectal Cancer Screening
OncoLink at ASCO 1999
Hepatic Infusion Increases Survival and Reduces Liver Metastases from Colorectal Cancer when Combined with Chemotherapy
OncoLink at ASTRO 1999
Intensity Modulated Radiation Therapy (IMRT) May Reduce Small Bowel, Rectum, and Bladder Complications in Patients with Cervical Cancer Treated to the Pelvis and Paraaortic Area
OncoLink at ASCO 1998
New Drug Expands Limited Treatment Arsenal for for Colorectal Cancer
OncoLink en espanõl
Share